Director of API retires
By Dylan Bushell-Embling
Thursday, 10 July, 2008
Thursday, 10 July, 2008
A director of Australian Pharmaceutical Industries [ASX: API], Barry Frost, announced his retirement today.
Frost has served on the company's board since 1993, and has been deputy chairman since 2001. His resignation will be effective July 31.
API, which markets and distributes prescription and over-the-counter medications, has announced that it is currently looking for replacement for the position.
Related News
Gene editing could make quolls resistant to cane toad toxin
Scientists from Colossal Biosciences and The University of Melbourne have introduced genetic...
New anti-clotting agent has its own 'off switch'
The anticoagulant's anti-clotting action can be rapidly stopped on demand, which could enable...
Genetic cause found for rare neurological disease
The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare movement...
